Hematologic Neoplasms: all 1,494 studies
Page 1 of 15. Open to participants first (438), then studies with results posted, then the rest; newest registration first within each.
- Phase 2 Study of Oral Epetraborole in Adults With Polycythemia VeraNot yet recruitingNCT07891533Phase 2
- Symptom Monitoring and Management Intervention After CAR-TNot yet recruitingNCT07886190Not applicable
- KATALYST-HEME-01: Study of the KAT6 Inhibitor MEN2312 in Heme MalignanciesNot yet recruitingNCT07873827Phase 1/2
- Effects of Resistance Training on Recovery During Hematopoietic Stem Cell TransplantationNot yet recruitingNCT07872813Not applicable
- BHF-COLLATE: UK Prospective, Multi-centre, Observational, Cardio-oncology Anthracycline RegistryNot yet recruitingNCT07864467
- Feasibility Study of a Sports-Inspired Onco-Coaching Progranm for Young Adults i Cancer RemissionRecruitingNCT07861971
- Effects of Synbiotic Supplementation on Gastrointestinal Symptoms, Appetite, and Nutritional Recovery in Patients After Autologous Bone Marrow TransplantNot yet recruitingNCT07845669Not applicable
- Cognitive Impairment in Older Adults With Hematologic MalignanciesNot yet recruitingNCT07842679
- Metagenomic Sequencing Across the Infectious Disease Risk and Care ContinuumNot yet recruitingNCT07825714
- Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 ExpressionNot yet recruitingNCT07809906Phase 1
- A Clinical Study to Evaluate CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematologic MalignanciesNot yet recruitingNCT07809139Phase 1
- A Phase I, Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematological MalignanciesNot yet recruitingNCT07809126Phase 1
- CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell TransplantationNot yet recruitingNCT07808112Phase 2
- Dose-Escalation/Expansion Study of iMagic in Relapsed/Refractory Hematologic MalignanciesNot yet recruitingNCT07802756Early Phase 1
- Home-based Intravenous Cytarabine Treatment for Acute Myeloid Leukemia: a National Danish Study of Feasibility, Costs, and ImplementationNot yet recruitingNCT07802015
- Musculoskeletal Ultrasound in Patients With Hematologic MalignanciesNot yet recruitingNCT07785505
- mNGS for IFD in Patients With Hematological MalignanciesNot yet recruitingNCT07763184
- Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia PatientsRecruitingNCT07763054
- Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in CancerRecruitingNCT07756034
- Safety and Tolerability of REGN17235 in Adult Participants With Clonal Cytopenia of Undetermined Significance and Low-Risk Myelodysplastic Syndrome With SF3B1 MutationNot yet recruitingNCT07753148Phase 1
- Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant ConditionsRecruitingNCT07743476
- Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant PatientsRecruitingNCT07724873Phase 1/2
- To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood CancersRecruitingNCT07719946Phase 2
- Rutgers University Study of the Genetics of Blood CancersRecruitingNCT07714044
- Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor TherapyNot yet recruitingNCT07711327
- Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic MalignanciesNot yet recruitingNCT07710781Not applicable
- Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to TransplantRecruitingNCT07709195Phase 2
- Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant PatientsRecruitingNCT07709013Phase 2
- A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)Not yet recruitingNCT07709000Phase 2
- Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.RecruitingNCT07708987Phase 2
- Ceftazidime-Avibactam PK/PD and Resistance in Hematology PatientsNot yet recruitingNCT07703644
- Wearable Data for Personalized Prognostication in Cancer: A Registry ProtocolNot yet recruitingNCT07691008
- Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCTRecruitingNCT07689630Phase 3
- Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.RecruitingNCT07679412Not applicable
- A Multicenter, Open-label, Non-randomized, Single-arm Phase 1/2 Study of Autologous Nano CD5-CAR T Cells for the Treatment of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/LymphomaNot yet recruitingNCT07678307Phase 1/2
- Take5Care+: A Self-management Educational InterventionNot yet recruitingNCT07674212Not applicable
- CD45RA-depleted DLI for the Prevention of Viral Infections in High-risk Patients After Haploidentical TransplantationNot yet recruitingNCT07672964Phase 1
- Cousin vs. Sibling Donors in Haplo-HSCTNot yet recruitingNCT07662382
- CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical TransplantationRecruitingNCT07662369Phase 1/2
- Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With Malignant Haematological Disorders and Severe ThrombocytopeniaRecruitingNCT07653672
- Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesRecruitingNCT07648264Phase 3
- Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological MalignanciesNot yet recruitingNCT07636486Phase 2/3
- Acalabrutinib Maleate and Bortezomib for Patients With HLA AntibodiesNot yet recruitingNCT07635511Phase 3
- Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods StudyNot yet recruitingNCT07634263
- A Phase 1/2 Study of KK2430 in Participants With Hematologic NeoplasmsRecruitingNCT07629726Phase 1/2
- Digitalized Exercise Fit Tool Intervention for Adolescents With Blood CancerNot yet recruitingNCT07621887Not applicable
- Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in EuropeNot yet recruitingNCT07621289
- Identifying Cellular and Molecular Determinants of Efficacy and Resistance in Patients Undergoing CAR-T TherapyRecruitingNCT07609485
- Robotic Dog Intervention on Emotional Well-Being and Quality of LifeNot yet recruitingNCT07607379Not applicable
- Early Discontinuation of Antibiotics in Paediatric High-risk Febrile NeutropeniaNot yet recruitingNCT07590648Phase 4
- HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCTRecruitingNCT07579065Not applicable
- A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesRecruitingNCT07572006Phase 1
- Clinical Study of the Safety and Efficacy of Allogeneic TCR-enhanced Vδ2 T Cell in Patients With Malignant Tumors.RecruitingNCT07570563Phase 1/2
- Complementary and Alternative Medicine Among Patients With Hematologic Malignancies in FranceNot yet recruitingNCT07541326Not applicable
- Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe MyelofibrosisNot yet recruitingNCT07539779Phase 2/3
- A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological MalignanciesNot yet recruitingNCT07532746Phase 1
- Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood CancersNot yet recruitingNCT07524530Phase 2
- Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic MalignanciesRecruitingNCT07523555Phase 1/2
- LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL)RecruitingNCT07519811Not applicable
- Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCTRecruitingNCT07511127Phase 3
- Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaRecruitingNCT07504458Phase 3
- Influenza Vaccination Strategy for Patients With Hematologic MalignancyRecruitingNCT07485855Phase 3
- Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic MalignanciesNot yet recruitingNCT07485504Phase 1
- Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical TrialsEnrolling by invitationNCT07474051
- variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia PathwayNot yet recruitingNCT07463976
- The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary InfiltratingNot yet recruitingNCT07456189Not applicable
- The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood TransplantationNot yet recruitingNCT07441967Phase 2
- DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.RecruitingNCT07440290Phase 2/3
- A Study of APG-3288 in Relapsed/Refractory Blood CancersRecruitingNCT07424833Phase 1
- Assessing DCog Short for Neurotoxicity in CAR-TRecruitingNCT07403812Not applicable
- Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 InjectionNot yet recruitingNCT07362732Early Phase 1
- Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological MalignanciesNot yet recruitingNCT07362602Early Phase 1
- MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)RecruitingNCT07362225
- A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell TransplantRecruitingNCT07359859Phase 2
- Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney TransplantationRecruitingNCT07358195Early Phase 1
- Orca-T Expanded Access Program Study for Patients With Advanced Hematologic MalignanciesAvailableNCT07346105
- A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic MalignanciesNot yet recruitingNCT07316907Phase 1
- Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the GutRecruitingNCT07305090
- Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood CancersRecruitingNCT07300735Not applicable
- A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological MalignanciesNot yet recruitingNCT07294300Phase 1
- Halt Aging in Survivors of Blood CancersRecruitingNCT07292272Not applicable
- Precision Physical Exercise for Personalized Onco-Hematology.Not yet recruitingNCT07286539Not applicable
- Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic MalignanciesRecruitingNCT07285668Not applicable
- Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile NeutropeniaRecruitingNCT07277387
- Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic MalignanciesRecruitingNCT07270263Not applicable
- CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and LymphomaRecruitingNCT07257419Phase 1
- A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic MalignanciesRecruitingNCT07255898Phase 1
- Prehabilitation to Improve Frailty, Function, and Quality of Life in Candidates for Hematopoietic Stem Cell TransplantationNot yet recruitingNCT07255521Not applicable
- Prophylactic DLI-X for Leukemia Relapse After HCTNot yet recruitingNCT07254793Phase 1
- Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by CoagulopathyNot yet recruitingNCT07234630
- A First-in-Human Trial of DS3790a in Participants With Hematological MalignanciesRecruitingNCT07220616Phase 1/2
- Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeRecruitingNCT07216443Phase 2
- ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy PeriodRecruitingNCT07203534Not applicable
- A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesRecruitingNCT07195916Phase 1
- Cancer and Immune Cell Metabolism in Patients With Hematological MalignanciesRecruitingNCT07189117
- Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) TherapyRecruitingNCT07186192Phase 3
- Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and SafetyRecruitingNCT07185503
- The Effect of a Protective Oral Care Protocol Using Peppermint Oil MouthwashNot yet recruitingNCT07179094Not applicable
- A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic MalignanciesRecruitingNCT07173595Phase 1
- Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T TherapyRecruitingNCT07173166Not applicable